Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
03 Aug 2023 |
SH01 |
Statement of capital following an allotment of shares on 2 August 2023
|
|
|
02 Aug 2023 |
PSC09 |
Withdrawal of a person with significant control statement on 2 August 2023
|
|
|
02 Aug 2023 |
PSC08 |
Notification of a person with significant control statement
|
|
|
02 Aug 2023 |
PSC07 |
Cessation of Timothy Mark Newton as a person with significant control on 21 July 2023
|
|
|
02 Aug 2023 |
RESOLUTIONS |
Resolutions
-
RES10 ‐
Resolution of allotment of securities
-
RES01 ‐
Resolution of adoption of Articles of Association
|
|
|
02 Aug 2023 |
MA |
Memorandum and Articles of Association
|
|
|
02 Aug 2023 |
MA |
Memorandum and Articles of Association
|
|
|
02 Aug 2023 |
RESOLUTIONS |
Resolutions
-
RES10 ‐
Resolution of allotment of securities
-
RES12 ‐
Resolution of varying share rights or name
-
RES13 ‐
All previous allotment of shares be ratified 21/07/2023
-
RES01 ‐
Resolution of adoption of Articles of Association
|
|
|
25 Jul 2023 |
AP01 |
Appointment of Mohammad Khobreh as a director on 21 July 2023
|
|
|
25 Jul 2023 |
AP01 |
Appointment of Mr Gregg Stephen Sando as a director on 21 July 2023
|
|
|
25 Jul 2023 |
AP01 |
Appointment of Gemma Elizabeth Olivia Sturt as a director on 21 July 2023
|
|
|
24 Jul 2023 |
TM01 |
Termination of appointment of Timothy Mark Newton as a director on 21 July 2023
|
|
|
31 Mar 2023 |
SH01 |
Statement of capital following an allotment of shares on 30 March 2023
|
|
|
28 Mar 2023 |
AA |
Total exemption full accounts made up to 31 March 2022
|
|
|
14 Feb 2023 |
AD01 |
Registered office address changed from C/O the Cambridge Partnership, the Dorothy Hodgkin Building Babraham Research Campus, Babraham Cambridge Default CB22 3FH United Kingdom to C/O the Cambridge Partnership, the Dorothy Hodgkin Building Babraham Research Campus, Babraham Cambridge CB22 3FH on 14 February 2023
|
|
|
14 Feb 2023 |
AD01 |
Registered office address changed from C/O the Cambridge Partnership the Dorothy Hodgkin Building Babraham Research Campus, Babraham Cambridge CB22 3AT United Kingdom to C/O the Cambridge Partnership, the Dorothy Hodgkin Building Babraham Research Campus, Babraham Cambridge Default CB22 3FH on 14 February 2023
|
|
|
08 Feb 2023 |
AP01 |
Appointment of Dr Nia Emami-Shahri as a director on 3 January 2023
|
|
|
16 Dec 2022 |
AP01 |
Appointment of Dr Nuno Francisco Vilhena Fernandes Madeira Do O as a director on 5 December 2022
|
|
|
14 Oct 2022 |
CS01 |
Confirmation statement made on 30 September 2022 with updates
|
|
|
12 Oct 2022 |
SH01 |
Statement of capital following an allotment of shares on 1 September 2022
|
|
|
12 Oct 2022 |
SH01 |
Statement of capital following an allotment of shares on 1 September 2022
|
|
|
12 Oct 2022 |
SH01 |
Statement of capital following an allotment of shares on 1 September 2022
|
|
|
15 Nov 2021 |
AA |
Total exemption full accounts made up to 31 March 2021
|
|
|
06 Oct 2021 |
CS01 |
Confirmation statement made on 30 September 2021 with updates
|
|
|
12 Nov 2020 |
CS01 |
Confirmation statement made on 30 September 2020 with updates
|
|